PARP1 and ovarian cancer: In agreement with our results, it has been reported that the expression of PARP1 is associated with the progression of various human malignant tumors, such as gastric cancer [15], breast cancer [17], ovarian cancer [18], glioblastoma [19], and chordoma [45].